Advisory Services Network’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$408K Buy
16,314
+894
+6% +$25.2K 0.01% 1399
2025
Q4
$485K Sell
15,420
-3,939
-20% -$131K 0.01% 1232
2025
Q3
$691K Sell
19,359
-750
-4% -$34.2K 0.01% 1048
2025
Q2
$975K Buy
20,109
+250
+1% +$14.1K 0.02% 835
2025
Q1
$1.16M Sell
19,859
-1,182
-6% -$80.7K 0.02% 705
2024
Q4
$1.69M Buy
21,041
+8,457
+67% +$723K 0.03% 548
2024
Q3
$769K Hold
12,584
0.02% 813
2024
Q2
$769K Buy
+12,584
New +$748K 0.02% 813

Other funds holding PRCT

Advisory Services Network's PRCT Position: Q1 2026 in Review

Advisory Services Network increased its Procept Biorobotics (PRCT) stake by 5.8% in Q1 2026, buying an estimated $25.2K and bringing the position to 16,314 shares worth $408K. The position accounts for 0.01% of the portfolio, ranked #1399.

Advisory Services Network first reported a position in PRCT in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.69M in Q4 2024. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Advisory Services Network held 16,314 shares of Procept Biorobotics worth $408K as of Q1 2026.
  • Advisory Services Network bought 894 Procept Biorobotics shares in Q1 2026, an estimated $25.2K.
  • Procept Biorobotics made up 0.01% of Advisory Services Network's portfolio in Q1 2026, its #1399 holding.
  • Advisory Services Network first reported a position in Procept Biorobotics in Q2 2024 and has held it in 8 quarters since.
  • Advisory Services Network's Procept Biorobotics position peaked at $1.69M in Q4 2024.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.